       |
LABORATORY INVESTIGATIONS
Paid medical service name |
Price of the investigation
(BYN) |
Clinical diagnostics laboratory |
"Triple" blood test (erythrocyte, leukocytes, erythrocyte sedimentation rate) |
3,61 |
Blood test for sugar |
2,83 |
Complete blood cell count |
8,72 |
Blood test (reticulocytes) |
3,57 |
Blood test (platelets) |
3,67 |
Common urine analysis |
2,26 |
Urine analysis by Nichiporenko method |
2,34 |
Zimnitskiy's test |
1,78 |
Feces analysis (coprogram) |
3,74 |
Feces analysis (Kato technique) |
2,50 |
Feces analysis (enterobiasis) |
2,55 |
Feces analysis (cryptosporidiosis) |
4,50 |
Feces analysis (lamblias) |
2,53 |
D-dimer testing |
16,80 |
Troponin results |
40,42 |
Biochemical analysis (analyser): |
|
Blood and processing sampling |
3,37 |
Na / K / Cl |
2,61 |
Total protein |
0,92 |
C-reactive protein |
1,60 |
Urea |
0,94 |
Creatinine |
0,93 |
Uric acid |
0,98 |
Glucose |
0,92 |
Albumin |
0,92 |
Total cholesterol |
0,93 |
HDL cholesterol |
2,57 |
Triacylglycerol |
1,02 |
Bilirubin |
1,02 |
Calcium |
0,94 |
AAT activity |
0,96 |
Alanine transaminase |
0,96 |
Alkaline phosphatase |
0,96 |
Gamma-glutamyl transpeptidase |
1,08 |
Magnesium |
1,19 |
Antistreptolysin O titer (ASO) test |
2,10 |
Rheumatoid factor in serum (latex test) |
2,07 |
Biochemical analysis (manually): |
|
Blood and processing sampling |
3,37 |
Total protein |
0,94 |
C-reactive protein |
0,77 |
Albumin |
0,79 |
Urea (kinetic method) |
1,37 |
Jaffe reaction (kinetic method) |
1,26 |
Uric acid (fermentation method) |
1,44 |
Glucose (fermentation method) |
1,66 |
Total cholesterol (fermentation method) |
1,63 |
HDL Cholesterol |
11,77 |
Triacylglycerol (fermentation method) |
2,62 |
Atherogenic index |
1,10 |
Bilirubin (method of Jendrassik, Kleggorn and Grof) |
1,76 |
Electrolytes (photometric method): |
|
potassium / K |
0,97 |
sodium / Na |
0,97 |
chlorine / Cl |
0,97 |
Calcium (with orthocresolphthalein complex) |
1,33 |
Magnesium (fermentation method) |
2,91 |
Enzyme analysis (kinetic method): |
|
AAT activity |
1,58 |
alanine transaminase |
1,58 |
alkaline phosphatase |
1,99 |
gamma-glutamyl transpeptidase |
1,78 |
Antistreptolysin O titer (ASO) test |
2,10 |
Rheumatoid factor in serum (latex test) |
2,07 |
Blood coagulation (coagulogram) |
22,50 |
Laboratory of serodiagnosis of infectious diseases |
Blood and processing sampling |
3,60 |
Blood for hormone levels (ELISA): |
|
Anti-Thyroid Peroxidase |
4,81 |
Thyroxine, T4 |
4,84 |
Thyroglobulin |
4,85 |
TSH |
4,84 |
Free Triiodthyronine, FT3 |
4,69 |
Progesterone |
5,08 |
Prolactin |
4,78 |
PSA |
4,38 |
Cancer antigen, CA-125 |
22,80 |
HIV test |
5,93 |
Test for hepatitis "B" |
6,20 |
Test for hepatitis "C" |
6,16 |
Clinical value of SARS-CoV2 IgM and IgG antibodies in diagnosis of COVID-19 (ELISA method) |
24,64 |
Research on COVID-19 (PCR method) |
45,25 |
Immunochromatography rapid test for COVID-19 |
27,08 |
Blood test for TORCH infections (ELISA): |
|
Rubella (German Measles) |
5,11 |
Cytomegalovirus infection |
5,11 |
Toxoplasmosis |
5,11 |
Herpes virus |
5,11 |
Cytologic laboratory |
Microsubsampling |
0,21 |
Diagnostic studies (cervix, cervical channel, vaginal canal, culdocentesis) |
4,83 |
Study of endoscopic material |
5,86 |
Dermatovenerologic dispensary |
Microscopic examination (ureaplasma and mycoplasma) |
11,90 |
Microscopic examination (ureaplasma and mycoplasma) - Mycoplasma (IST) |
21,16 |
Test for gonorrhoea (inoculation) |
14,65 |
Microscopic examination (flora and gonorrhea) |
5,55 |
RW blood test |
12,81 |
Blood test for chlamydia |
13,18 |
Study of Demodex mites |
1,51 |
Blood transfusion station |
Blood and processing sampling |
3,37 |
Blood group (isohemagglutinating serum) |
4,47 |
Blood group (monoclonal reagents in venous blood) |
3,67 |
Rh testing (express method) |
3,62 |
Immunohematology studies (agglutination method): |
|
Determination of alloimmune anti-erythrocyte antibodies (indirect antiglobulin test in a gel test system using ID-cards on an ID-centrifuge) |
9,29 |
Determination of the titer of alloimmune anti-erythrocyte antibodies (indirect antiglobulin test in a gel test system using ID cards on an ID centrifuge) |
40,23 |
Psychiatrical narcological dispensary |
Detection of narcotic drugs, psychotropic and other substances that cause intoxication and poisoning (immunochromatographic assay) |
12,06 |
Individual manipulations |
Pipetting: |
|
glass pipettes |
0,91 |
semi-automatic batcher |
0,23 |
automatic batcher |
0,21 |
Sampling |
0,41 |
Fingerstick: |
|
for hematological and biochemical studies, international normalized attitude (INR) |
1,17 |
for all hematology studies |
1,69 |
Blood sampling from the vein |
1,90 |
Processing of venous blood to produce plasma or serum |
1,06 |
Overall clinical laboratory studies |
Urine examination (manual method): |
|
Determination of the amount, color, transparency, presence of precipitate, relative density, pH |
0,35 |
Glucose detection (express test) /
each subsequent |
0,45 /
0,16 |
Protein detection: |
|
express test /
each subsequent |
0,45 /
0,16 |
with sulfosalicylic acid |
0,31 |
Determination of protein: |
|
with sulfosalicylic acid /
each subsequent |
1,79 /
1,38 |
with pyrogallol red /
each subsequent |
2,58 /
2,17 |
ketosis (express test) /
each subsequent |
0,43 /
0,14 |
bilirubin detection (express test) /
each subsequent |
0,40 /
0,10 |
urobilinoids (express test) /
each subsequent |
0,40 /
0,10 |
Microscopic examination of sediment: |
|
norm /
each subsequent |
1,15 /
0,85 |
pathology (albuminuria) /
each subsequent |
1,63 /
1,21 |
Nechiporenko's test |
2,34 |
Zimnitskiy's test |
1,78 |
Nose examination (rhinocytogram analysis),
one localization |
2,15 |
Stool analysis: |
|
Determination of color, shape, odor, impurities, mucus, pH |
0,30 |
Fecal occult blood test (benzidine test) |
0,61 |
Microscopic examination (in 3 preparats) |
3,45 |
Physical examination of the genitourinary system tract (urethra, cervical canal, vagina, prostatic fluid): |
|
Microscopic examination: |
|
of preparations of native material (1 material) |
1,04 |
of preparations stained with methylene blue /
each subsequent |
2,01 /
1,73 |
of preparations stained with the Gram's method /
each subsequent |
3,13 /
2,35 |
Investigation of the vaginal smear: functional state of the ovaries (vaginal epithelial cells, kariopicnotic index (KPI), Maturation Index (MI) /
each subsequent |
2,88 /
2,69 |
Overall clinical parasitological studies: |
|
Detection of helminth eggs by the method of Kato (1 preparat) |
2,50 |
Study scraping on enterobiasis (in 3 preparats) |
2,55 |
Detection of Cryptosporidium in stool samples (microscopic method) |
4,50 |
Stool analysis for Giardiasis |
2,53 |
Research studies register |
0,39 |
Hematologic examinations |
Manual preparation of peripheral blood for cytomorphological examination (making of blood smears, fixation, coloring) /
each subsequent |
2,04 /
0,58 |
Microscopic (morphological) analysis of cells in a peripheral blood preparation with a description of the elements (visual and microscopic examinations): |
|
no abnormality |
1,64 |
with pathological changes |
4,23 |
Hemoglobin estimation /
each subsequent |
0,66 /
0,46 |
Red Blood Cell Count (RBC) |
1,03 |
Reticulocyte Count |
3,57 |
Platelet calculation (Fonio's method) |
3,67 |
Absolute WBC count |
0,82 |
Investigation of a blood sample using hematological automatic analyzers, without differentiation of the leukocyte formula /
each subsequent |
2,92 /
1,65 |
Erythrocyte sedimentation rate |
0,43 |
Bone marrow research: |
|
Preparation of a bone marrow preparation for a cytomorphological study (making of bone marrow smears, fixation, coloring) /
each subsequent |
2,04 /
0,78 |
Microscopic (morphological) analysis of bone marrow cells (myelogram) |
16,76 |
Cytological studies |
Biomaterial registration |
0,21 |
Exfoliative cytology: |
|
Biomaterials gynecological (cervical screening): |
|
Two-stage microscopy system: |
|
Manufacture of microscopic preparations and primary microscopic examination |
1,55 |
Microscopic examination of smears with pathological changes |
2,85 |
Single-stage microscopy system: |
|
Cytogram with details of the revealed changes and the formulation of the conclusion |
3,79 |
Diagnostic testings: |
|
from the cervix, or cervical canal, or vagina, or vulva, or IUD |
4,83 |
from the uterine cavity |
5,67 |
Research of scrapings: |
|
from the surface of erosions, ulcers, wounds, fistulas, nipple of the breast |
4,45 |
from the surface of tumorous or pigmented skin formations |
6,04 |
Sputum examination |
6,02 |
Urine examination |
5,19 |
Puncture cytology: |
|
Study of punctate or smears (trepanobiopsy or excisional biopsy or intraoperatively from tumors of different localization: from the lacteal gland, or thyroid, or prostate, or skin, or bone marrow) |
6,41 |
Study of punctate or smears (trepanobiopsy or excisional biopsy or intraoperatively from tumors of different localization: from formations in the head and neck, or lungs, or mediastinum, or liver, or pancreas, or spleen, or gall bladder, or kidneys, or ureters, or bladder, or testicles, or ovaries, or soft tissues, or bones , or retroperitoneal tumors, or lymph nodes, or tumors of the nervous system) |
7,54 |
Investigation of biological fluids (pleural fluid, ascitic fluid, spinal fluid, or other) |
6,40 |
Study of endoscopic material |
5,86 |
Revision (consultation) of finished micropreparations |
6,28 |
Biochemical studies |
Study of blood plasma: |
|
Conducting research using single-channel biochemical photometers: |
|
total protein /
each subsequent |
0,94 /
0,72 |
C-reactive protein /
each subsequent |
0,77 /
0,54 |
albumin /
each subsequent |
0,79 /
0,57 |
urea (kinetic method) /
each subsequent |
1,37 /
0,98 |
Jaffe reaction (kinetic method) /
each subsequent |
1,26 /
0,87 |
uric acid (fermentation method) /
each subsequent |
1,44 /
1,05 |
glucose (fermentation method) /
each subsequent |
1,66 /
1,07 |
total cholesterol (fermentation method) /
each subsequent |
1,63 /
0,94 |
HDL cholesterol /
each subsequent |
11,77 /
10,53 |
triacylglycerol (fermentation method) /
each subsequent |
2,62 /
2,06 |
atherogenic index |
1,10 |
Bilirubin (method of Jendrassik, Kleggorn and Grof) /
atherogenic index |
1,76 /
1,37 |
potassium / K (photometric method) /
atherogenic index |
0,97 /
0,49 |
sodium / Na (photometric method) /
atherogenic index |
0,97 /
0,49 |
chlorine / Cl (photometric method) /
atherogenic index |
0,97 /
0,49 |
calcium (with orthocresolphthalein complex) /
atherogenic index |
1,33 /
0,85 |
magnesium (photometric method) /
atherogenic index |
2,91 /
2,42 |
AAT activity (kinetic method) /
atherogenic index |
1,58 /
1,29 |
alanine transaminase (kinetic method) /
atherogenic index |
1,58 /
1,29 |
alkaline phosphatase (kinetic method) /
atherogenic index |
1,99 /
1,11 |
gamma-glutamyl transpeptidase (kinetic method) /
atherogenic index |
1,78 /
1,49 |
Conducting research using multichannel biochemical auto-analyzers of average performance (with manual registration of research results): |
|
Na / K / CL |
2,61 |
total protein |
0,92 |
C-reactive protein |
1,60 |
urea |
0,94 |
creatinine |
0,93 |
uric acid |
0,98 |
glucose |
0,92 |
albumin |
0,92 |
total cholesterol |
0,93 |
HDL cholesterol |
2,57 |
triacylglycerol |
1,02 |
bilirubin |
1,02 |
calcium |
0,94 |
AAT activity |
0,96 |
alanine transaminase |
0,96 |
alkaline phosphatase |
0,96 |
gamma-glutamyl transpeptidase |
1,08 |
magnesium |
1,19 |
Determination of the concentration of electrolytes using automatic ion-selective analyzers (1 sample) /
each subsequent |
4,25 /
3,47 |
Whole blood study: |
|
Determination of the concentration of electrolytes using automatic ion-selective analyzers (1 sample) |
3,91 |
Examination of cerebrospinal fluid: |
|
Gluco-test (fermentation method) /
each subsequent |
3,99 /
3,41 |
Studies of the state of hemostasis |
Processing of venous blood to produce plasma without platelets |
1,31 |
Registration of research results /
each subsequent |
2,72 /
0,93 |
Screening: |
|
Activated partial thromboplastin time (APTT) /
each subsequent |
4,75 /
2,00 |
Thromboplastin time with a thromboplastin-calcium mixture /
each subsequent |
4,94 /
2,18 |
Determination of fibrinogen in the blood plasma /
each subsequent |
6,46 /
5,35 |
Immunologic study |
Enzyme immunoassay (ELISA) (hormones; oncomarkers, markers of allergies, antibodies to viral and bacterial antigens, markers of immune status, markers of autoimmune pathology, cytokines, growth factors and other markers in biological fluids): |
|
Preparation of samples /
each subsequent |
2,84 /
0,79 |
Semi-automated analysis (ELISA): |
|
antibodies to the thyroid peroxide /
each subsequent |
4,81 /
2,93 |
Thyroxine, T4 /
each subsequent |
4,84 /
2,95 |
thyroglobulin /
each subsequent |
4,85 /
2,96 |
TSH /
each subsequent |
4,84 /
2,95 |
Free Triiodthyronine, FT3 /
each subsequent |
4,69 /
2,80 |
progesterone /
each subsequent |
5,08 /
3,20 |
Prolactin /
each subsequent |
4,78 /
2,90 |
PSA /
each subsequent |
4,38 /
2,50 |
oncomarker CA-125 /
each subsequent |
18,48 /
16,60 |
HIV test /
each subsequent |
6,42 /
4,54 |
test for hepatitis "B" /
each subsequent |
6,38 /
4,50 |
test for hepatitis "C" /
each subsequent |
6,16 /
4,27 |
test for TORCH infections (Rubella) /
each subsequent |
5,11 /
3,22 |
test for TORCH infections (Herpes virus) /
each subsequent |
5,11 /
3,22 |
test for TORCH infections (Cytomegalovirus infection) /
each subsequent |
5,11 /
3,22 |
test for TORCH infections (Toxoplasmosis) /
each subsequent |
5,11 /
3,22 |
ELISA ("strip" technology) /
each subsequent |
3,00 /
1,07 |
Immunochromatography: |
|
Quantitation of D-dimers/
each subsequent |
16,80 /
15,70 |
Quantification of troponin /
each subsequent |
40,42 /
39,32 |
Immunohematology: |
|
Determination of blood groups according to the ABO system by a cross method using isohemagglutinating sera and standard red blood cells (in venous blood) /
each subsequent |
4,47 /
3,09 |
Determination of blood groups according to the ABO system and Rh-factor using monoclonal reagents (in venous blood)/
each subsequent |
3,67 /
2,30 |
Determination of Rh-factor by express method in test tubes without heating (in venous blood) /
each subsequent |
3,62 /
2,24 |
Conduction of immunohematological studies by agglutination in gel: |
|
Determination of alloimmune anti-erythrocyte antibodies (indirect antiglobulin test in a gel test system using ID-cards on an ID-centrifuge) |
9,29 |
Determination of the titer of alloimmune anti-erythrocyte antibodies (indirect antiglobulin test in a gel test system using ID cards on an ID centrifuge) |
40,23 |
Determination of the concentration of major classes and subclasses of immunoglobulins (ELISA): |
|
Preparation of samples /
each subsequent |
3,42 /
0,89 |
Semi-automated analysis: chlamydia /
each subsequent |
5,24 /
3,36 |
Determination of the activity of anti-O-streptolysin in serum: |
|
Latex-test /
each subsequent |
2,10 /
0,74 |
Determination of rheumatoid factor in serum: |
|
Latex-test /
each subsequent |
2,07 /
0,71 |
Diagnosis of syphilis: |
|
Determination of immunoglobulins for Treponema pallidum (ELISA): |
|
semi-automated analysis /
each subsequent |
4,88 /
1,82 |
"strip" technology /
each subsequent |
2,41 /
0,80 |
Microprecipitation test with cardiolipin antigen: |
|
with inactivated native serum -
qualitative method (1 study) |
6,62 |
with inactivated native serum - qualitative method (1 in a series) |
1,46 |
with inactivated native serum - quantitative method |
2,37 |
Microbiological studies |
Studies on aerobic and facultative anaerobic microorganisms (urethra, genitals): |
|
Culture assay (in the absence of microorganisms) |
9,46 |
Culture assay (presence of microorganisms) with the study of morphological properties: |
|
1-2 microorganisms |
10,59 |
3 or more microorganisms |
11,73 |
Studies of ureaplasma and mycoplasma |
19,61 |
Detection of Demodex foliorum hominis |
1,51 |
Preparation, coloring and microscopic examination of preparations of biological material: |
|
methylene blue /
each subsequent |
1,91 /
1,30 |
Gram's method /
each subsequent |
3,87 /
2,79 |
Chemical-toxicological studies |
Immune Research: |
|
Detection of narcotic drugs, psychotropic and other substances that cause intoxication and poisoning (express method) /
each subsequent |
3,71 /
2,18 |
Detection of narcotic drugs, psychotropic and other substances that cause intoxication and poisoning (immunochromatographic assay) /
each subsequent |
12,06 /
11,09 |
|
|